Potency Evaluation of Unfractionated Heparins Commercialized in Brazil through Anti-Factor Xa and Anti-Factor IIa Chromogenic Tests and Coagulation Assay: Vigil Sanit Debate, Rio De Janeiro, 2023, v.11: E01923 | Publicado Em: 11 05 2023. Vigil Sanit Debate 2023, 11, 1-10. https://doi.org/10.22239/2317-269x.01923.